Nardi test
Nardi Test is a medical diagnostic procedure used to evaluate the function of the thyroid gland. The test is named after the Italian endocrinologist, Dr. Giovanni Nardi, who first developed the procedure in the early 20th century.
Overview[edit | edit source]
The Nardi Test is a type of thyroid function test that measures the body's response to a synthetic form of thyrotropin-releasing hormone (TRH). This hormone is produced by the hypothalamus and stimulates the pituitary gland to release thyroid-stimulating hormone (TSH), which in turn stimulates the thyroid gland to produce and release thyroid hormones.
Procedure[edit | edit source]
During the Nardi Test, a small amount of synthetic TRH is injected into the patient's body. Blood samples are then taken at regular intervals to measure the levels of TSH in the bloodstream. An increase in TSH levels following the injection of TRH indicates a normal response, while a lack of increase or a delayed increase may suggest a problem with the thyroid or pituitary gland.
Uses[edit | edit source]
The Nardi Test is primarily used to diagnose hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormones. It can also be used to differentiate between primary hypothyroidism, which is caused by a problem with the thyroid gland itself, and secondary hypothyroidism, which is caused by a problem with the pituitary gland or hypothalamus.
Risks and Complications[edit | edit source]
As with any medical procedure, the Nardi Test carries some risks. These may include allergic reactions to the synthetic TRH, bruising or infection at the injection site, and false positive or false negative results. Patients should discuss these risks with their doctor before undergoing the test.
See Also[edit | edit source]
Nardi test Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD